Oncolytics Biotech (ONCY) Enterprise Value Growth (5y) (2014 - 2025)
Oncolytics Biotech (ONCY) Enterprise Value Growth (5y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.31% |
| Sep 30, 2025 | 19.60% |
| Jun 30, 2025 | 18.80% |
| Dec 31, 2024 | -2.48% |
| Sep 30, 2024 | -3.16% |
| Jun 30, 2024 | -8.16% |
| Mar 31, 2024 | -9.10% |
| Dec 31, 2023 | -19.83% |
| Sep 30, 2023 | -12.96% |
| Jun 30, 2023 | 6.99% |
| Mar 31, 2023 | -8.68% |
| Dec 31, 2022 | 1.60% |
| Sep 30, 2022 | -1,676.25% |
| Jun 30, 2022 | 93.08% |
| Mar 31, 2022 | 99.50% |
| Dec 31, 2021 | -25.33% |
| Sep 30, 2021 | 88.72% |
| Jun 30, 2021 | -81.66% |
| Mar 31, 2021 | 92.78% |
| Dec 31, 2020 | 93.69% |